ID: ALA4776400

Max Phase: Preclinical

Molecular Formula: C18H18F3N7O

Molecular Weight: 405.38

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cc(-c2nn[nH]n2)nc(N2CCC(COc3ccccc3C(F)(F)F)C2)n1

Standard InChI:  InChI=1S/C18H18F3N7O/c1-11-8-14(16-24-26-27-25-16)23-17(22-11)28-7-6-12(9-28)10-29-15-5-3-2-4-13(15)18(19,20)21/h2-5,8,12H,6-7,9-10H2,1H3,(H,24,25,26,27)

Standard InChI Key:  HAUPESFXXGVGPB-UHFFFAOYSA-N

Associated Targets(Human)

Plasma retinol-binding protein 718 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Transthyretin 2847 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 405.38Molecular Weight (Monoisotopic): 405.1525AlogP: 2.89#Rotatable Bonds: 5
Polar Surface Area: 92.71Molecular Species: ACIDHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.37CX Basic pKa: 1.76CX LogP: 3.96CX LogD: 2.53
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.70Np Likeness Score: -1.89

References

1. Cioffi CL,Muthuraman P,Raja A,Varadi A,Racz B,Petrukhin K.  (2020)  Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.,  63  (19): [PMID:32878437] [10.1021/acs.jmedchem.0c00996]

Source